Leadership & Expert Views - Cancer Currents Blog
Commentaries from scientific leaders at NCI and other institutions about cancer research topics, programs, and initiatives.
-
Companies that want to market e-cigarettes in the United States must now submit applications to the Food and Drug Administration (FDA). In this interview, Mitch Zeller, director of FDA’s Center for Tobacco Products, provides insights into FDA actions on e-cigarettes.
-
NCI Director Dr. Ned Sharpless discusses progress against childhood cancers, like CAR T-cell therapy and collecting more comprehensive data on children and adolescents with cancer, and the need to better address disparities in childhood cancer.
-
In this Q&A, leaders of NCI’s SeroNet program discuss new research findings on the immune response to the virus that causes COVID-19, new variants of the virus, and the COVID-19 vaccines. They also discuss the effects of the vaccines on people with cancer.
-
The director of NCI’s Division of Cancer Prevention, Dr. Philip Castle, discusses the division’s priority areas and his vision for making more rapid progress in cancer prevention, including moving toward precision prevention and immunoprevention.
-
Following the death of Dr. Emil Freireich in February, NCI Director Norman E. Sharpless reflects on the accomplishments and legacies of Dr. Freireich and several other cancer research luminaries who have passed in recent years.
-
The week after the globe recognized World Cancer Day and NCI staff were honored with a virtual visit from First Lady Dr. Jill Biden, the NCI director kicks off the commemoration of the 50th anniversary of the National Cancer Act of 1971.
-
With the Cancer Moonshot having reached its midway point, NCI Director Dr. Ned Sharpless and Deputy Director Dr. Dinah Singer provide a report on the progress to date and future directions for this ambitious initiative to accelerate progress against cancer.
-
In a study using data from more than 3 million people, NCI researchers have found that people who have antibodies to SARS-CoV-2, the virus that causes COVID-19, appear to have some degree of protection against being reinfected with the virus.
-
Drs. Ned Sharpless and Sanya Springfield highlight NCI’s YES program, which is encouraging young students from underrepresented populations to become interested and engaged in cancer research.
-
Dr. Satish Gopal, director of NCI’s Center for Global Health, discusses opportunities for making progress against cancer worldwide, particulary in low- and middle-income countries, many of which are seeing increasing cancer incidence and deaths.